Clinical Trials Browser

Has results × Lymphoma, Large B-Cell, Diffuse × epratuzumab × Clear all

NCT00301821 2019-10-09

Monoclonal Antibody Therapy and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma

Phase 2 Completed

107 enrolled 8 charts

Lymphoma, Lymphoma, Large B-Cell, Diffuse